Home / NEWS / Health Care / Biogen Alzheimer’s drug and the battle over dementia treatment of the future

Biogen Alzheimer’s drug and the battle over dementia treatment of the future

Biogen Alzheimer’s dope Aduhelm is the first new treatment for dementia approved by the FDA in decades, and it’s started a war over the brain drug pipeline.

Check Also

23andMe special committee again rejects CEO Wojcicki’s take-private offer

Anne Wojcicki, co-founder and chief boss officer of 23andme Inc., during the South by Southwest …

Leave a Reply

Your email address will not be published. Required fields are marked *